Chie Shibazaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chie Shibazaki has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Motoyasu Adachi
National Institutes for Quantum Science and Technology
3 shared publications - Haruki Sugiyama
Institute for Molecular Science
2 shared publications - Kazuhiro Akutsu-Suyama
Neutron Science and Technology Center, Comprehensive Research Organization for Science and Society (CROSS), Tokai, Naka 319-1106, Ibaraki, Japan
2 shared publications - Misaki Ueda
Neutron Science and Technology Center, Comprehensive Research Organization for Science and Society (CROSS), 162-1 Shirakata, Tokai, Naka, Ibaraki 319-1106, Japan
2 shared publications - Suzanne Zoë Fisher
Lund Protein Production Platform and Protein Production Sweden, Department of Biology, Lund University, Sölvegatan 35, 22362 Lund, Sweden
2 shared publications - Takayuki Oku
Japan Proton Accelerator Research Complex (J-PARC) Center Japan Atomic Energy Agency 2-4 Shirakata Tokai Ibaraki319-1195 Japan
2 shared publications
Latest Publications
- Open Access
Regulating Light-Harvesting Protein Assembly through Engineered Trimers of Phycocyanin and Allophycocyanin
Phycobilisome-associated phycobiliproteins naturally assemble into trimeric and hexameric architectures, making it difficult to isolate stable trimeric species for structural and functional studies. Here, we establish a rational strategy to generate stable trimers of phycocyanin (TeCPC) and allophycocyanin (TeAPC) from Thermosynechococcus elongatus by destabilizing the hexamerization interface. We introduce structure-guided glycine-to-arginine substitutions, G29R in TeCPC and G21R in TeAPC, to suppress hexamer formation. In TeCPC, an additional T121Y substitution in the α-subunit further stabilizes the trimeric assembly, which was identified through screening of structure-based variants. Recombinant expression in Escherichia coli produced holoproteins with native-like chromophorylation. Size-exclusion chromatography, mass spectrometry, and X-ray crystallography confirm the homogeneous trimers, with no evidence of hexamer formation under the conditions examined. Thermal analyses demonstrate melting temperature exceeding 69 °C for both engineered complexes. These results provide a general framework for obtaining stable phycobiliprotein trimers for structural and spectroscopic investigations, and for controlling phycobiliprotein quaternary structure.
Open AccessRegulating Light-Harvesting Protein Assembly through Engineered Trimers of Phycocyanin and Allophycocyanin
Phycobilisome-associated phycobiliproteins naturally assemble into trimeric and hexameric architectures, making it difficult to isolate stable trimeric species for structural and functional studies. Here, we establish a rational strategy to generate stable trimers of phycocyanin (TeCPC) and allophycocyanin (TeAPC) from Thermosynechococcus elongatus by destabilizing the hexamerization interface. We introduce structure-guided glycine-to-arginine substitutions, G29R in TeCPC and G21R in TeAPC, to suppress hexamer formation. In TeCPC, an additional T121Y substitution in the α-subunit further stabilizes the trimeric assembly, which was identified through screening of structure-based variants. Recombinant expression in Escherichia coli produced holoproteins with native-like chromophorylation. Size-exclusion chromatography, mass spectrometry, and X-ray crystallography confirm the homogeneous trimers, with no evidence of hexamer formation under the conditions examined. Thermal analyses demonstrate melting temperature exceeding 69 °C for both engineered complexes. These results provide a general framework for obtaining stable phycobiliprotein trimers for structural and spectroscopic investigations, and for controlling phycobiliprotein quaternary structure.
- Open Access
- 16 September 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (9) , 981
Development of the Direct Deuteration Method for Amino Acids and Characterization of Deuterated Tryptophan
Proteins and peptides are vital biomolecules, and deuterated amino acids are increasingly applied in areas such as drug discovery, metabolic tracing, and neutron scattering studies. In this study, we performed deuteration on all 20 proteinogenic amino acids, including their side chains, and established efficient methods for 13 amino acids. Using a Pt/C-catalyzed hydrogen–deuterium exchange reaction, the reaction parameters were optimized to achieve the selective and stable incorporation of deuterium. In addition, the resulting deuterated compounds, focusing on tryptophan, were characterized in order to assess their physicochemical properties. Because the deuteration reaction caused significant racemization of amino acids, deuterated D/L-tryptophan was isolated using a chiral separation method. Deuterated tryptophan characterization studies confirmed that the photostability was markedly enhanced by deuteration, whereas the acid stability showed no clear isotopic effect. The X-ray crystal structure analyses revealed minimal changes upon the hydrogen-to-deuterium substitution. These results provide a robust platform for the supply of deuterated amino acids, facilitating their application in drug development, structural analysis, and creation of advanced functional biomaterials.
- 16 September 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (9) , 981
Open AccessDevelopment of the Direct Deuteration Method for Amino Acids and Characterization of Deuterated Tryptophan
Proteins and peptides are vital biomolecules, and deuterated amino acids are increasingly applied in areas such as drug discovery, metabolic tracing, and neutron scattering studies. In this study, we performed deuteration on all 20 proteinogenic amino acids, including their side chains, and established efficient methods for 13 amino acids. Using a Pt/C-catalyzed hydrogen–deuterium exchange reaction, the reaction parameters were optimized to achieve the selective and stable incorporation of deuterium. In addition, the resulting deuterated compounds, focusing on tryptophan, were characterized in order to assess their physicochemical properties. Because the deuteration reaction caused significant racemization of amino acids, deuterated D/L-tryptophan was isolated using a chiral separation method. Deuterated tryptophan characterization studies confirmed that the photostability was markedly enhanced by deuteration, whereas the acid stability showed no clear isotopic effect. The X-ray crystal structure analyses revealed minimal changes upon the hydrogen-to-deuterium substitution. These results provide a robust platform for the supply of deuterated amino acids, facilitating their application in drug development, structural analysis, and creation of advanced functional biomaterials.
- Open Access
- 25 July 2025
- Published by MDPI AG in Preprints.org
Development of the Direct Deuteration Method for Amino Acids and Characterization of Deuterated Tryptophan
Proteins and peptides are essential biomolecules involved in the maintenance of biological functions and disease development. Their structural and functional analyses are crucial for drug discovery and pathology. Amino acids, the fundamental building blocks of these biomolecules, are increasingly utilized in deuterated forms in diverse fields, such as metabolic tracing and neutron scattering studies. In this study, we have developed an efficient deuteration method that targets all 20 proteinogenic amino acids, including their side chains. Using a Pt/C-catalyzed hydrogen–deuterium exchange reaction, the reaction parameters were optimized to achieve the selective and stable incorporation of deuterium. In addition, the resulting deuterated compounds, focusing on tryptophan, were characterized in order to assess their physicochemical properties. Because the deuteration reaction caused significant racemization of amino acids, deuterated D/L-tryptophan was isolated using a chiral separation method. Deuterated tryptophan characterization studies confirmed that the photostability was markedly enhanced by deuteration, whereas the acid stability showed no clear isotopic effect. The X-ray crystal structure analyses revealed minimal changes upon the hydrogen-to-deuterium substitution. These results provide a robust platform for the supply of deuterated amino acids, facilitating their application in drug development, structural analysis, and creation of advanced functional biomaterials.
- 25 July 2025
- Published by MDPI AG in Preprints.org
Open AccessDevelopment of the Direct Deuteration Method for Amino Acids and Characterization of Deuterated Tryptophan
Proteins and peptides are essential biomolecules involved in the maintenance of biological functions and disease development. Their structural and functional analyses are crucial for drug discovery and pathology. Amino acids, the fundamental building blocks of these biomolecules, are increasingly utilized in deuterated forms in diverse fields, such as metabolic tracing and neutron scattering studies. In this study, we have developed an efficient deuteration method that targets all 20 proteinogenic amino acids, including their side chains. Using a Pt/C-catalyzed hydrogen–deuterium exchange reaction, the reaction parameters were optimized to achieve the selective and stable incorporation of deuterium. In addition, the resulting deuterated compounds, focusing on tryptophan, were characterized in order to assess their physicochemical properties. Because the deuteration reaction caused significant racemization of amino acids, deuterated D/L-tryptophan was isolated using a chiral separation method. Deuterated tryptophan characterization studies confirmed that the photostability was markedly enhanced by deuteration, whereas the acid stability showed no clear isotopic effect. The X-ray crystal structure analyses revealed minimal changes upon the hydrogen-to-deuterium substitution. These results provide a robust platform for the supply of deuterated amino acids, facilitating their application in drug development, structural analysis, and creation of advanced functional biomaterials.